Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Ljubica Vazdar"'
Autor:
Mirjana Pavlović-Mavić, Petra Linarić, Ljubica Vazdar, Ana Tečić-Vuger, Petra Jakšić, Robert Šeparović
Publikováno v:
Libri Oncologici, Vol 51, Iss 2-3, Pp 109-118 (2023)
Body composition changes could indicate health conditions and potential health risks. Although several methods are currently available for quantitative assessment, each has limitations. Indirect methods are most frequently used because of their avail
Externí odkaz:
https://doaj.org/article/14d8fcc1aeed436a822539ffe66e0001
Publikováno v:
Acta Clinica Croatica, Vol 61., Iss 4, Pp 605-612 (2022)
Body composition has been studied relatively recently as part of oncology trials in different types of tumors. There are numerous studies that define the impact of chemotherapy side effects on the quality of life (QoL) of breast cancer patients, ho
Externí odkaz:
https://doaj.org/article/852e5b81a0f14f02aa28d439e6418e87
Autor:
Ljubica Vazdar, Ivo Darko Gabrić, Ivan Kruljac, Hrvoje Pintarić, Robert Šeparović, Lora Stanka Kirigin Biloš, Mirjana Pavlović, Ana Tečić Vuger, Mario Štefanović
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Trastuzumab has improved the prognosis of HER2 positive breast cancer, but cardiotoxicity remains a concern. We aimed to identify risk factors for trastuzumab-induced cardiotoxicity, with an emphasis on the HER2 Ile655Val single nucleotide p
Externí odkaz:
https://doaj.org/article/b0792d63096946bf96cbd11450c1c581
Autor:
Ana Tečić-Vuger, Robert Šeparović, Ljubica Vazdar, Mirjana Pavlović, Petra Linarić, Sanda Šitić, Martina Šepetavc, Damir Vrbanec
Publikováno v:
Libri Oncologici, Vol 49, Iss 1, Pp 20-28 (2021)
Tumor stimulates specific innate and acquired immune mechanisms. Main carriers of body’s immune response to tumor are T lymphocytes and main mechanism is killing of tumor cells by cytotoxic T lymphocytes CD8 +. In some cases, immune system can also
Externí odkaz:
https://doaj.org/article/e57271a45e0f4dc0b44ca5c75d8df961
Autor:
Ana Tečić-Vuger, Robert Šeparović, Ljubica Vazdar, Mirjana Pavlović, Petra Lepetić, Sanda Šitić, Božena Šarčević, Damir Vrbanec
Publikováno v:
Libri Oncologici, Vol 48, Iss 1, Pp 20-26 (2020)
Androgen receptors (AR) are ligand-dependent nuclear transcription factors. These are steroid receptors, similar to estrogen receptors (ER). They are expressed in numerous cells in the body, with different constructive roles. AR signalling can be inv
Externí odkaz:
https://doaj.org/article/e675f03ec5d54e988e0048657e7140fc
Autor:
Ana Tečić Vuger, Robert Šeparović, Ljubica Vazdar, Mirjana Pavlović, Petra Lepetić, Sanda Šitić, Žarko Bajić, Božena Šarčević, Damir Vrbanec
Publikováno v:
Acta Clinica Croatica, Vol 59., Iss 1., Pp 97-107 (2020)
Triple-negative breast cancer (TNBC) occurs in around one-sixth of all breast cancer (BC) patients, with the most aggressive behavior and worst prognosis of all BC subtypes. It is a heterogeneous disease, with specific molecular characteristics and n
Externí odkaz:
https://doaj.org/article/46703ac2ee474f09acb499d757115aa0
Publikováno v:
Cancers, Vol 13, Iss 23, p 5922 (2021)
Knowledge about the patient’s experience and perception of side effects and their impact on daily life is crucial for the adequate planning of interventions to provide the highest attainable levels of quality of life during oncology treatment. We c
Externí odkaz:
https://doaj.org/article/867ed0b3df3241b197aa744321021327
Autor:
Ana Tecic Vuger, Melita Peric Balja, Petra Jaksic, Petra Linaric, Mirjana Pavlovic Mavic, Ljubica Vazdar, Robert Separovic
Publikováno v:
Cancer Research. 83:P1-05
Neoadjuvant, i.e. preoperative, systemic antineoplastic treatment (NAT), in patients with breast cancer enables in vivo monitoring of tumor response to applied therapy, tailoring treatment in real –time accordingly, sparing surgical procedures, bet
Autor:
Sanda Šitić, Ljubica Vazdar, Mirjana Pavlovic, Ingrid Belac-Lovasić, Ana Tečić Vuger, Robert Šeparović, Damir Vrbanec
Publikováno v:
Cancer Research. 81:PS6-56
INTRODUCTIONAnalyzes reported to date on TIL in TNBC have evaluated mostly stromal (sTIL) and possibly intratumoral TIL (iTIL), but none evaluated TIL spatially, separately in compartments of central tumor (CT) and invasive margin (IM). Also, none ev
Autor:
Ana Tečić Vuger, Robert Šeparović, Sanda Šitić, Ljubica Vazdar, Mirjana Pavlović, Damir Vrbanec
Aims This study aimed to investigate the association between tumor-infiltrating lymphocytes (TIL) and androgen receptors (AR) and to assess their impact on early triple-negative breast cancer (TNBC) prognosis. Previous studies analyzed only stromal T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8de5b5fca811f5dd6844f87c690a8284
https://doi.org/10.21203/rs.3.rs-927413/v1
https://doi.org/10.21203/rs.3.rs-927413/v1